A Cerebral Frailty Risk Score Integrating Frailty Index and Neuroimaging for Dementia Prediction in the UK Biobank
Kan, C. N.; Chew, J.; Lim, W. S.; Tan, C. H.
Show abstract
Frailty is a multisystem clinical syndrome closely linked to cognitive aging, yet its cerebral underpinnings and co-contribution to adverse outcomes remain poorly understood. In 63,509 dementia-free UK Biobank participants (aged 65.0{+/-}7.7), higher frailty index (FI) was associated with multiple neuroimaging markers, including reduced hippocampal volume, decreased cortical thickness, greater white matter hyperintensities burden, and impaired brain diffusion metrics. FI and neuroimaging markers additively increased the risks of incident dementia and mortality. An extreme gradient boosting with accelerated failure time framework highlighted FI and key regional neuroimaging features in dementia risk prediction (nested C-index=0.825, iAUC=0.759). Integrating the top 10 predictors into a novel point-based cerebral frailty risk score (CFRS) showed strong performance in predicting dementia onset (optimism-corrected C-index=0.838, iAUC=0.778), and was robust to the competing risk of mortality. These findings highlight the potential utility of a CFRS framework that integrates cumulative systemic and cerebral vulnerabilities for dementia risk stratification.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Default mode network tau predicts future clinical decline in atypical early Alzheimer’s disease 96%
- Tau-first subtype of Alzheimer's disease consistently identified across in vivo and post mortem studies 95%
- Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome 95%
Similar papers in this journal
- Magnitude and Kinetics of a set of Neuroanatomic Volume and Thickness together with White Matter Hyperintensity is definitive of Cognitive Status and Brain Age 95%
- Polygenic resilience scores capture protective genetic effects for Alzheimer’s disease 94%
- The circulating proteome and brain health: Mendelian randomisation and cross-sectional analyses 94%